Jena, Germany

Robert Eilers

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert Eilers: A Pioneer in Pharmaceutical Crystallization

Introduction: Robert Eilers, an accomplished inventor based in Jena, Germany, has made significant contributions to the field of pharmaceuticals through his innovative approaches to crystallization. With three patents to his name, Eilers has focused on enhancing the stability and purity of active pharmaceutical ingredients, thereby improving drug delivery systems.

Latest Patents: Eilers's latest patents showcase his pioneering work in producing high-quality microparticles and crystals. One of his key inventions is the patent for "Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs." This method enables the production of highly crystalline and stable microparticles with a narrow size distribution, crucial for fast-release dosage forms of pharmaceuticals. The microparticles are designed to maintain stability largely independent of the physiochemical properties of the active substance.

Another notable patent is the "Arrangement and method for producing high-purity crystals." This invention outlines a countercurrent crystallization process for temperature-sensitive pharmaceutical agents. The innovative arrangement consists of multiple crystallizers and mother liquor lines that facilitate the generation of a controlled mother liquor flow. This method enhances the purity of the crystallization product, thereby ensuring a higher quality output for pharmaceutical applications.

Career Highlights: Throughout his career, Robert Eilers has collaborated with reputable companies, including Jesalis Pharma GmbH and Hapila GmbH. His research and development efforts have emphasized the importance of producing pharmaceuticals with improved formulations and delivery systems, which are essential for patient care and efficacy.

Collaborations: Eilers has had the opportunity to work alongside notable colleagues such as Detlef Grawe and Sabine Gliesing. Their combined expertise further strengthens the innovative solutions developed for the pharmaceutical industry.

Conclusion: Robert Eilers exemplifies the spirit of innovation in the pharmaceutical sector. His dedication to the advancement of drug formulation and the production of high-purity crystals highlights the critical role inventors play in improving healthcare outcomes. With his patents, Eilers continues to pave the way for more effective and stable pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…